Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol

European Radiology

Volumn 26, Issue 3, 2016, Pages 807-815

  Stojanov, Dragan A ^a,b   Aracki Trenkic, Aleksandra ^b   Vojinovic, Slobodan ^a,b   Benedeto Stojanov, Daniela ^a   Ljubisavljevic, Srdjan ^a,b  

^a UNIVERSITY OF NI   (Serbia)

^b CLINICAL CENTER NIS   (Serbia)

Author keywords

Contrast media; Dentate nucleus; Gadolinium deposition; Globus pallidus; Magnetic resonance imaging

Indexed keywords

GADOBUTROL; GADOLINIUM; CONTRAST MEDIUM; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DENTATE NUCLEUS; FEMALE; GLOBUS PALLIDUS; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PONS; PRIORITY JOURNAL; RADIATION RESPONSE; SIGNAL DETECTION; ANALYSIS OF VARIANCE; BRAIN DISEASE; CEREBELLUM NUCLEUS; COMPARATIVE STUDY; DOSE RESPONSE; EVALUATION STUDY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; THALAMUS; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; BRAIN DISEASES; CEREBELLAR NUCLEI; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOBUS PALLIDUS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES; THALAMUS; YOUNG ADULT;

EID: 84957939950     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3879-9     Document Type: Article

References (39)

1. Giesel F, Mehndiratta A, Essig M (2010) High-relaxivity contrast enhanced magnetic resonance neuroimaging: a review. Eur Radiol 20:2461–2474
2. Caravan P, Ellison JJ, Mcmurry TJ, Lauferr JB (1999) Gadolinium (III) Chelates as MRI contrast agents: structures, dynamics and applications. Chem Rev 99:2293–2352
3. Bellin MF, Vasile M, Morel-Prtecetti S (2003) Currently used non-specific extracellular MR contrast media. Eur Radiol 13:2688–2698
4. Pietsch H, Lengsfeld P, Jost G et al (2009) Long-term retention of gadolinium in the skin of following the administration of gadolinium based contrast agents. Eur Radiol 19:1417–1424
5. Sieber MA, Pietsch H, Walter J et al (2008) A preclinical study to investigate the development of Nephrogenic Systemic Fibrosis: a possible role for gadolinium-based contrast media. Investig Radiol 43:65–75
6. Sieber MA, Pietsch H, Walter J et al (2008) Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in-vivo and to trigger nephrogenic systemic fibrosis-like lesions. Eur Radiol 18:2164–2173
7. Kanda T, Ishii K, Kawaguchi K et al (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834–841
8. Roccatagliata L, Vuolo L, Bonzano L et al (2009) Multiple sclerosis: hyperintense dentate nucleus on unenhanced T1-weighted images is associated with the secondary progressive subtype. Radiology 251:503–510
9. Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revision to the Mc Donald criteria. Ann Neurol 69:292–302
10. Kasahara S, Miki Y, Kanagaki M et al (2011) Hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with a history of brain irradiation. Radiology 258:222–258
11. LeVine SM (1997) Iron deposits in multiple sclerosis and Alzheimer’s disease brains. Brain Res 760:298–303
12. Chan DE, Pan HC, Ho DM et al (2007) Presence of activated microglia in a high-signal lesion on T1-weighted MR images: a biopsy sample re-examined. AJNR Am J Neuroradiol 28:602
13. Drayer B, Burger P, Hurwitz B et al (1987) Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 149:357–363
14. Brass SD, Chen NK, Mulkern NV, Bakshi R (2006) Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging 17:31–40
15. Drayer BP, Burger P, Hurwtz B et al (1987) Magnetic resonance imaging in multiple sclerosis: decreased signal in thalamus and putamen. Ann Neurol 22:546–550
16. Craelius W, Migdal MW, Luessenhop CP et al (1982) Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 106:397–399
17. Shin JC, Kim E, Sheong HK et al (2007) High signal intensity on magnetic resonance imaging as a predictor of neurobehavioral performance of workers exposed to manganese. Neurotoxicology 28:257–262
18. Fujioka M, Taoka T, Matsuo Y et al (2003) Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration. Ann Neurol 54:732–747
19. Powell T, Sussman JG, Davies-Jones GA (1992) MR imaging in acute multiple sclerosis: ring-like appearance in plaque suggesting the presence of paramagnetic free radicals. AJNR Am J Neuroradiol 13:1544–1546
20. Terada H, Barkovich AJ, Edwards MS, Ciricillo SM (1996) Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1. AJNR Am J Neuroradiol 17:755–760
21. Daszkiewicz OK, Hennel JW, Szczepkowski TW, Lubas B (1963) Proton magnetic relaxation and protein hydration. Nature 200:1006–1007
22. Henkelman RM, Watts JF, Kucharzyk W (1991) High signal intensity in MR images of calcified brain tissue. Radiology 179:199–206
23. Boyko OB, Burger PC, Shelburne JD, Ingram P (1992) Non-heme mechanisms for T1 shortening: pathologic, CT, and MR elucidation. AJNR Am J Neuroradiol 13:1439–1445
24. Warakaulle DR, Anslow P (2003) Differential diagnosis of intracranial lesions with high signal on T1 or low signal on T-2 weighted MRI. Clin Radiol 58:922–933
25. Suzuki S, Nishio S, Takata K et al (2000) Radiation-induced brain calcification: paradoxical high signal intensity in T1-weighted images. Acta Neurochir (Wien) 142:801–804
26. Weinmann HJ, Gries H, Speck U (1992) Fundamental physics and chemistry: Types of contrast agents. In: Sartor K (ed) MR imaging of the skull and brain: a correlative text atlas. Springer-Verlag, New York, NY, pp 26–28
27. Hegde A, Mohan S, Lath N, Lim CCT (2011) Differential diagnosis for bilateral abnormalities of basal ganglia and thalamus. Radiographics 31:5–30
28. Kim TJ, Kim TO, Kim WS et al (2006) MR imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. AJNR Am J Neuroradiol 2:1373–1378
29. Lai PH, Chen C, Liang HL, Pan HB (1999) Hyperintense basal ganglia on T1-weighted MR imaging. AJNR Am J Neuroradiol 172:1109–1115
30. Valdés Hernández Mdel C, Maconick LC, Tan EM, Wardlaw JM (2012) Identification of mineral deposits in the brain on radiological images: a systematic review. Eur Radiol 22:2371–2381
31. Brunberg JA, Kanal E, Hirsch W, Van Thiel DH (1991) Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T. AJNR Am J Neuroradiol 12:909–914
32. Rovira A, Alonso J, Cordoba J (2008) MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol 29:1612–1621
33. Oikonomu A, Chatzistefanou A, Zezos P et al (2012) Basal ganglia hyperintensity on T1-weighted MRI in Rendu-Osler-Weber disease. J Magn Reson Imaging 35:426–430
34. Mirowitz SA, Westicks TJ, Hirsch JD (1991) Hyperdense basal ganglia on T1-weighted images in patients receiving parenteral nutrition. Radiology 181:117–120
35. da Silva CJ, da Rocha AJ, Jeronymo S et al (2007) A preliminary study revealing a new association in patients undergoing maintenance hemodialysis: manganism symptoms and T1 hyperintense changes in the basal ganglia. AJNR Am J Neuroradiol 28:1474–1479
36. Martin-Duverneuil N, Idbaih A, Hoang-Xuan K et al (2006) MRI features of neurodegenerative Langerhans cell histiocytosis. Eur Radiol 16:2074–2082
37. White GW, Gibby WA, Tweedle MF (2006) Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-D03A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Investig Radiol 41:272–278
38. Shellock FG, Kanal E (1999) Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 10:477–484
39. Tweedle MF, Wedeking P, Krishan K (1995) Biodistribution of radiolabeled, formulated gadopentenate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Investig Radiol 30:371–380